Financhill
Sell
47

LGND Quote, Financials, Valuation and Earnings

Last price:
$108.98
Seasonality move :
6.43%
Day range:
$108.19 - $113.14
52-week range:
$67.53 - $129.90
Dividend yield:
0%
P/E ratio:
43.50x
P/S ratio:
12.94x
P/B ratio:
2.45x
Volume:
86.4K
Avg. volume:
126.3K
1-year change:
51.07%
Market cap:
$2.1B
Revenue:
$131.3M
EPS (TTM):
$2.51

Earnings Data

Next earnings date for LGND
Feb 27
2025
Most recent earnings per share
-$0.39
Missed by $1.74
(Nov 7/2024)
Consensus Estimate
$1.35
(Nov 7/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

LGND Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/27/2025 Q4 $39M -- -- $1.19 --
11/07/2024 Q3 $40.6M $51.8M -$0.39 $1.35 -$1.74
08/06/2024 Q2 $34.3M $41.5M -$2.88 $1.06 -$3.94
05/07/2024 Q1 $27.9M $31M $4.75 $0.83 $3.92
02/27/2024 Q4 $25.6M $28.1M $1.03 $0.66 $0.37
11/08/2023 Q3 -- -- -$0.59 $0.62 -$1.21
08/08/2023 Q2 -- -- $0.13 $0.66 -$0.53
05/04/2023 Q1 -- -- $2.33 $0.89 $1.44
02/22/2023 Q4 -- -- -$1.04 $1.12 -$2.16
11/07/2022 Q3 -- -- $0.02 $0.43 -$0.41
08/08/2022 Q2 -- -- -$0.05 $0.43 -$0.48
05/04/2022 Q1 -- -- -$0.91 $0.66 -$1.57
02/17/2022 Q4 -- -- -$0.30 $1.37 -$1.67
11/09/2021 Q3 -- -- $0.80 $1.04 -$0.24
07/29/2021 Q2 -- -- $1.79 $1.36 $0.43
05/03/2021 Q1 -- -- $1.05 $1.13 -$0.08
02/03/2021 Q4 -- -- $0.35 $1.09 -$0.74
10/30/2020 Q3 -- -- -$0.42 $0.98 -$1.40
08/03/2020 Q2 -- -- $1.32 $0.76 $0.56
05/06/2020 Q1 -- -- -$1.46 $0.66 -$2.12
02/06/2020 Q4 -- -- -$0.43 $0.65 -$1.08
11/05/2019 Q3 -- -- -$0.81 $0.62 -$1.43
07/30/2019 Q2 -- -- -$0.74 $0.55 -$1.29
05/02/2019 Q1 -- -- $31.32 $15.45 $15.87
02/07/2019 Q4 -- -- -$2.02 $1.22 -$3.24
11/08/2018 Q3 -- -- $2.80 $1.03 $1.77
08/06/2018 Q2 -- -- $2.99 -- --
05/08/2018 Q1 -- -- $1.83 -- --
02/21/2018 Q4 -- -- -$0.33 -- --
11/09/2017 Q3 -- -- $0.36 -- --
08/07/2017 Q2 -- -- $0.26 -- --
05/09/2017 Q1 -- -- $0.22 -- --
02/23/2017 Q4 -- -- -$0.15 -- --
11/03/2016 Q3 -- -- $0.05 -- --
08/04/2016 Q2 -- -- -$0.30 -- --
05/04/2016 Q1 -- -- $0.30 -- --
02/10/2016 Q4 -- -- $0.29 -- --
11/09/2015 Q3 -- -- $9.28 -- --
08/05/2015 Q2 -- -- $1.11 -- --
05/11/2015 Q1 -- -- $0.04 -- --
02/09/2015 Q4 -- -- $0.34 -- --

Ligand Pharmaceuticals Earnings Questions

  • How Much did Ligand Pharmaceuticals Generate in Revenue Last Quarter?

    Ligand Pharmaceuticals reported $51.8M worth of top line sales in its most recent quarter.

  • Did Ligand Pharmaceuticals Beat Earnings Last Quarter?

    Ligand Pharmaceuticals announced earnings per share of -$0.39 which represents a miss of analyst forecast a $1.35 per share.

  • Is Ligand Pharmaceuticals Profitable?

    Ligand Pharmaceuticals reported $49.4M that represents $2.68 per share over the last quarter.

  • What is the Analyst Consensus for Ligand Pharmaceuticals EPS Next Year?

    Ligand Pharmaceuticals's earnings are forecast to grow from $2.94 per share to $5.35 per share next year representing an increase of 92.04%.

  • When is Ligand Pharmaceuticals's Earnings Date?

    Ligand Pharmaceuticals's next earnings date is February 27, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Is Coinbase Stock Going Down?
Why Is Coinbase Stock Going Down?

Every way you look at it, Coinbase has had a…

Is Uber Stock a Buy on the Dip?
Is Uber Stock a Buy on the Dip?

Shares of Uber Technologies (NYSE:UBER) have been fading fast in…

Is AMD Stock an All-Time Buy?
Is AMD Stock an All-Time Buy?

Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 115x

Buy
54
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 36x

Alerts

Sell
50
LMND alert for Dec 28

Lemonade [LMND] is down 10.69% over the past day.

Sell
50
TSLL alert for Dec 28

Direxion Daily TSLA Bull 2X Shares [TSLL] is down 9.92% over the past day.

Buy
63
SMLR alert for Dec 28

Semler Scientific [SMLR] is down 9.65% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock